Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
Solveig Tiepolt, Philipp Meyer, Marianne Patt, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. Supplement 1, pp. 33S-44S
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Basal forebrain cholinergic signalling: development, connectivity and roles in cognition
Mala Ananth, Prithviraj Rajebhosale, Ronald Kim, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 4, pp. 233-251
Open Access | Times Cited: 62
Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART
Alexander J. Ehrenberg, Michael A. Kelberman, Kathy Liu, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 5, pp. 2182-2196
Open Access | Times Cited: 34
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Alvin V. Terry, Keri Jones, Daniel Bertrand
Pharmacological Research (2023) Vol. 191, pp. 106764-106764
Open Access | Times Cited: 34
Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing
Isabella F. Orlando, James M. Shine, Trevor W. Robbins, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105167-105167
Open Access | Times Cited: 33
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wenbo Wang, Da Pan, Qi Liu, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1232-1232
Open Access | Times Cited: 11
Sinomenine regulates the cholinergic anti-inflammatory pathway to inhibit TLR4/NF-κB pathway and protect the homeostasis in brain and gut in scopolamine-induced Alzheimer’s disease mice
H. Ni, Muqiu Liu, Mindie Cao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116190-116190
Open Access | Times Cited: 10
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 10
Nicotinic acetylcholine receptors: Key targets for attenuating neurodegenerative diseases
Lydia J. Bye, Rocio K. Finol‐Urdaneta, Han‐Shen Tae, et al.
The International Journal of Biochemistry & Cell Biology (2023) Vol. 157, pp. 106387-106387
Closed Access | Times Cited: 17
State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer’s disease: Challenges and opportunities
Nina Engels, Elouise A. Koops, Prokopis C. Prokopiou, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104998-104998
Open Access | Times Cited: 25
Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [18F]-VAT
Jodi J. Weinstein, Scott J. Moeller, Greg Perlman, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 5, pp. 352-364
Closed Access | Times Cited: 4
3-(3-(diethylamino)propyl)-2-(4-(methylthio)phenyl)thiazolidin-4-one Attenuates Scopolamine-induced Cognitive Impairment in Rats: Insights Into Neuroprotective Effects
Anita Ávila de Souza, Kelen Cristiane Machado Goularte, Raphaela Cassol Piccoli, et al.
Molecular Neurobiology (2025)
Closed Access
Relationships among cortical activation, cognition, and blood biomarkers in two types of dementia determined using functional near-infrared spectroscopy
Nairong Ruan, Liang Ming, Yuehong Liu, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
Carlo Matera, Claudio Papotto, Clelia Dallanoce, et al.
Pharmacological Research (2023) Vol. 194, pp. 106813-106813
Open Access | Times Cited: 10
Breaking Barriers: Exploring Neurotransmitters through In Vivo vs. In Vitro Rivalry
Gabriel Lachance, Dominic Gauvreau, Élodie Boisselier, et al.
Sensors (2024) Vol. 24, Iss. 2, pp. 647-647
Open Access | Times Cited: 3
Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission
Cecilia Boccalini, Daniela Perani, Valentina Garibotto
Handbook of clinical neurology (2025), pp. 137-153
Closed Access
Imaging Cholinergic Receptors in the Brain by Positron Emission Tomography
Jing‐Jing Zhang, Hualong Fu, Ruofan Lin, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10889-10916
Open Access | Times Cited: 9
New Advances in the Exploration of Esterases with PET and Fluorescent Probes
Alba Gil-Rivas, Beatriz de Pascual‐Teresa, Irene Ortín, et al.
Molecules (2023) Vol. 28, Iss. 17, pp. 6265-6265
Open Access | Times Cited: 9
Increased Enzymatic Activity of Acetylcholinesterase Indicates the Severity of the Sterile Inflammation and Predicts Patient Outcome following Traumatic Injury
Aleksandar R. Zivkovic, Georgina M. Paul, Stefan Hofer, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 267-267
Open Access | Times Cited: 8
Post-COVID-Syndrom – Fokus Fatigue
Sabine Hellwig, Katharina Domschke
Der Nervenarzt (2022) Vol. 93, Iss. 8, pp. 788-796
Open Access | Times Cited: 14
Lower levels of cortical [3H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficits
Brian Dean, Vahram Haroutunian, Elizabeth Scarr
Schizophrenia Research (2023) Vol. 255, pp. 274-282
Closed Access | Times Cited: 7
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques
Özgül Ekmekçioğlu, Nathalie L. Albert, Kathrin Heinrich, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 2, pp. 237-246
Closed Access | Times Cited: 2
Clinical Applications of PET Imaging in Alzheimer’s Disease
Shiv Patil, Cyrus Ayubcha, Eric M. Teichner, et al.
PET Clinics (2024) Vol. 20, Iss. 1, pp. 89-100
Closed Access | Times Cited: 2
Recent progress of small-molecule-based theranostic agents in Alzheimer's disease
Furong Gao, Jiefang Chen, Yuancun Zhou, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 11, pp. 2231-2245
Open Access | Times Cited: 6
ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience
Ángel García de Lucas, Urpo Lamminmäki, Francisco R. López-Picón
Biomolecules (2023) Vol. 13, Iss. 1, pp. 164-164
Open Access | Times Cited: 4
Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer’s Disease
Jason K Russell, Alexander C. Conley, Jo Ellen Wilson, et al.
Current topics in behavioral neurosciences (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top